Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Critical nodes in signalling pathways: insights into insulin action

Nature Reviews Molecular Cell Biology volume 7, pages 85–96 (2006)Cite this article

Key Points

  • Cell-signalling networks are complex systems that allow for the specific biological response to a defined stimulus. We argue that it is possible to qualitatively identify the important mediators of any ligand–receptor system through a method that conceptualizes the most important genes as critical nodes.

  • A 'critical node' is defined as a group of related proteins (for example, gene isoforms) that are essential for the receptor-mediated signal, and in which two or more of these related proteins might have unique biological roles within a signalling network and therefore serve as a source of divergence within the signalling system. The node is highly regulated, both positively and negatively, and is a junction for potential crosstalk with other signalling systems.

  • Here, we use the insulin-signalling pathway as a model system. Three groups of genes are used as examples of 'critical nodes': the insulin receptor and its substrates (IR/IRS), phosphatidylinositol 3-kinase (PI3K) and AKT/protein kinase B (PKB). Although many proteins could be considered to be significant players in insulin signalling, only these three have attained sufficient in vivo and in vitro evidence to be considered 'critical nodes'.

  • The IRSs are a critical node because six isoforms exist, with most of insulin's signal being mediated by IRS1 and IRS2. These IRS proteins, and others, have been shown, through knockout and RNAi studies, to have different biological functions in vivo. These proteins are regulated, both positively by the insulin receptor, and negatively through serine phosphorylation and downregulation of protein levels. The IRS proteins also mediate crosstalk with other signalling systems, particularly with the inflammation pathways.

  • PI3K is also a critical node because both of its subunits, p85 and p110, have many different isoforms, many of which have unique biological functions. The p85α isoform is of particular interest because it negatively regulates insulin action independently of its function in the PI3K holoenzyme. This p85α subunit might also mediate crosstalk with the inflammatory pathways through the activation of c-Jun N-terminal kinase (JNK).

  • AKT/PKB is a critical node because it has been shown to be crucial for glucose homeostasis. AKT comes in three isoforms, and is subject to considerable positive and negative regulation, both by other kinases and by proteins that bind to and inhibit AKT. Many of insulin's downstream functions are mediated by AKT, including the activation of glycogen synthesis, the suppression of gluconeogenesis and the regulation of cell growth and cell size.

Abstract

Physiologically important cell-signalling networks are complex, and contain several points of regulation, signal divergence and crosstalk with other signalling cascades. Here, we use the concept of 'critical nodes' to define the important junctions in these pathways and illustrate their unique role using insulin signalling as a model system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Evolution of our concepts on signalling pathways.
Figure 2: Critical nodes in the insulin-signalling network.
Figure 3: Structure and interacting partners of the insulin-receptor substrates.
Figure 4: Isoform-specific functions of IRS proteins.
Figure 5: PI3K as a critical node.
Figure 6: AKT/PKB as a critical node.

Similar content being viewed by others

References

  1. Avruch, J. Insulin signal transduction through protein kinase cascades. Mol. Cell Biochem. 182, 31–48 (1998).

    Article  CAS  PubMed  Google Scholar 

  2. Ullrich, A. & Schlessinger, J. Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203–212 (1990).

    CAS  PubMed  Google Scholar 

  3. Elchebly, M. et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283, 1544–1548 (1999).

    Article  CAS  PubMed  Google Scholar 

  4. Ueki, K., Kondo, T. & Kahn, C. R. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol. Cell Biol. 24, 5434–5446 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Emanuelli, B. et al. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice. J. Biol. Chem. 276, 47944–47949 (2001).

    Article  CAS  PubMed  Google Scholar 

  6. Friedman, J. E. et al. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat. Am. J. Physiol. 273, E1014–E1023 (1997).

    CAS  PubMed  Google Scholar 

  7. Sun, X. J. et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73–77 (1991).

    Article  CAS  PubMed  Google Scholar 

  8. Sun, X. J. et al. Role of IRS-2 in insulin and cytokine signalling. Nature 377, 173–177 (1995).

    Article  CAS  PubMed  Google Scholar 

  9. Lavan, B. E., Lane, W. S. & Lienhard, G. E. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J. Biol. Chem. 272, 11439–11443 (1997).

    Article  CAS  PubMed  Google Scholar 

  10. Fantin, V. R. et al. Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells. J. Biol. Chem. 273, 10726–10732 (1998).

    Article  CAS  PubMed  Google Scholar 

  11. Cai, D., Dhe-Paganon, S., Melendez, P. A., Lee, J. & Shoelson, S. E. Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J. Biol. Chem. 278, 25323–25330 (2003).

    Article  CAS  PubMed  Google Scholar 

  12. Lehr, S. et al. Identification of major tyrosine phosphorylation sites in the human insulin receptor substrate Gab-1 by insulin receptor kinase in vitro. Biochemistry 39, 10898–10907 (2000).

    Article  CAS  PubMed  Google Scholar 

  13. Baumann, C. A. et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407, 202–207 (2000).

    Article  CAS  PubMed  Google Scholar 

  14. Gustafson, T. A., He, W., Craparo, A., Schaub, C. D. & O'Neill, T. J. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell Biol. 15, 2500–2508 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Virkamaki, A., Ueki, K. & Kahn, C. R. Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest. 103, 931–943 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Myers, M. G. Jr et al. The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling. J. Biol. Chem. 273, 26908–26914 (1998).

    Article  CAS  PubMed  Google Scholar 

  17. Algenstaedt, P., Antonetti, D. A., Yaffe, M. B. & Kahn, C. R. Insulin receptor substrate proteins create a link between the tyrosine phosphorylation cascade and the Ca2+-ATPases in muscle and heart. J. Biol. Chem. 272, 23696–23702 (1997).

    Article  CAS  PubMed  Google Scholar 

  18. Fei, Z. L., D'Ambrosio, C., Li, S., Surmacz, E. & Baserga, R. Association of insulin receptor substrate 1 with simian virus 40 large T antigen. Mol. Cell Biol. 15, 4232–4239 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Zick, Y. Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance. Sci. STKE 2005, PE4 (2005).

    Article  PubMed  Google Scholar 

  20. Bouzakri, K. et al. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. Diabetes 52, 1319–1325 (2003).

    Article  CAS  PubMed  Google Scholar 

  21. Harrington, L. S. et al. The TSC1–2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166, 213–223 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Miller, B. S. et al. Activation of cJun NH2-terminal kinase/stress-activated protein kinase by insulin. Biochemistry 35, 8769–8775 (1996).

    Article  CAS  PubMed  Google Scholar 

  23. Cai, D. et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nature Med. 11, 183–190 (2005).

    Article  CAS  PubMed  Google Scholar 

  24. Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333–336 (2002).

    Article  CAS  PubMed  Google Scholar 

  25. Aguirre, V., Uchida, T., Yenush, L., Davis, R. & White, M. F. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275, 9047–9054 (2000). An important paper that established the connection between Ser307 phosphorylation, JNK and insulin resistance.

    Article  CAS  PubMed  Google Scholar 

  26. Craparo, A., Freund, R. & Gustafson, T. A. 14-3-3 (ε) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner. J. Biol. Chem. 272, 11663–11669 (1997).

    Article  CAS  PubMed  Google Scholar 

  27. Bard-Chapeau, E. A. et al. Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action. Nature Med. 11, 567–571 (2005).

    Article  CAS  PubMed  Google Scholar 

  28. Hirashima, Y. et al. Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway. J. Endocrinol. 179, 253–266 (2003).

    Article  CAS  PubMed  Google Scholar 

  29. Rui, L., Yuan, M., Frantz, D., Shoelson, S. & White, M. F. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277, 42394–42398 (2002).

    Article  CAS  PubMed  Google Scholar 

  30. Shimomura, I. et al. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol. Cell 6, 77–86 (2000).

    Article  CAS  PubMed  Google Scholar 

  31. Sesti, G. et al. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J. 15, 2099–2111 (2001).

    Article  CAS  PubMed  Google Scholar 

  32. Araki, E. et al. Alternative pathway of insulin signaling in targeted disruption of the IRS-1 gene. Nature 372, 186–190 (1994).

    Article  CAS  PubMed  Google Scholar 

  33. Kubota, N. et al. Insulin receptor substrate 2 plays a crucial role in β cells and the hypothalamus. J. Clin. Invest. 114, 917–927 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Withers, D. J. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900–904 (1998).

    Article  CAS  PubMed  Google Scholar 

  35. Tseng, Y. H. et al. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nature Cell Biol. 7, 601–611 (2005).

    Article  CAS  PubMed  Google Scholar 

  36. Miki, H. et al. Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation. Mol. Cell Biol. 21, 2521–2532 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Huang, C., Thirone, A. C., Huang, X. & Klip, A. Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in l6 myotubes. J. Biol. Chem. 280, 19426–19435 (2005).

    Article  CAS  PubMed  Google Scholar 

  38. Taniguchi, C. M., Ueki, K. & Kahn, R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J. Clin. Invest. 115, 718–727 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Sun, X. J. et al. The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Mol. Endocrinol. 11, 251–262 (1997).

    Article  CAS  PubMed  Google Scholar 

  40. Miura, A. et al. Insulin substrates 1 and 2 are corequired for activation of atypical protein kinase C and Cbl-dependent phosphatidylinositol 3-kinase during insulin action in immortalized brown adipocytes. Biochemistry 43, 15503–15509 (2004).

    Article  CAS  PubMed  Google Scholar 

  41. Tsuruzoe, K., Emkey, R., Kriauciunas, K. M., Ueki, K. & Kahn, C. R. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling. Mol. Cell Biol. 21, 26–38 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Inoue, G., Cheatham, B., Emkey, R. & Kahn, C. R. Dynamics of insulin signaling in 3T3-L1 adipocytes. Differential compartmentalization and trafficking of insulin receptor substrate (IRS)-1 and IRS-2. J. Biol. Chem. 273, 11548–11555 (1998).

    Article  CAS  PubMed  Google Scholar 

  43. Ogihara, T. et al. Insulin receptor substrate (IRS)-2 is dephosphorylated more rapidly than IRS-1 via its association with phosphatidylinositol 3-kinase in skeletal muscle cells. J. Biol. Chem. 272, 12868–12873 (1997).

    Article  CAS  PubMed  Google Scholar 

  44. Sawka-Verhelle, D., Tartare-Deckert, S., White, M. F. & Van Obberghen, E. Insulin receptor substrate-2 binds to the insulin receptor through its phosphotyrosine-binding domain and through a newly identified domain comprising amino acids 591–786. J. Biol. Chem. 271, 5980–5983 (1996).

    Article  CAS  PubMed  Google Scholar 

  45. Myers, M. G. Jr et al. IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domains of p85. Proc. Natl Acad. Sci. USA 89, 10350–10354 (1992).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Cheatham, B. et al. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell Biol. 14, 4902–4911 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Alessi, D. R. et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 7, 261–269 (1997). Describes the discovery of PDK1.

    Article  CAS  PubMed  Google Scholar 

  48. Le Good, J. A. et al. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281, 2042–2045 (1998).

    Article  CAS  PubMed  Google Scholar 

  49. Sarbassov, D. D., Guertin, D. A., Ali, S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098–1101 (2005).

    Article  CAS  PubMed  Google Scholar 

  50. Maehama, T. & Dixon, J. E. PTEN: a tumour suppressor that functions as a phospholipid phosphatase. Trends Cell Biol. 9, 125–128 (1999).

    Article  CAS  PubMed  Google Scholar 

  51. Wijesekara, N. et al. Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol. Cell Biol. 25, 1135–1145 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Tang, X., Powelka, A. M., Soriano, N. A., Czech, M. P. & Guilherme, A. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes. J. Biol. Chem. 280, 22523–22529 (2005).

    Article  CAS  PubMed  Google Scholar 

  53. Sleeman, M. W. et al. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nature Med. 11, 199–205 (2005).

    Article  CAS  PubMed  Google Scholar 

  54. Shepherd, P. R., Withers, D. J. & Siddle, K. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem. J. 333, 471–490 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Yu, J. et al. Regulation of the p85/p110 phosphatidylinositol 3′-kinase: stabilization and inhibition of the p110α catalytic subunit by the p85 regulatory subunit. Mol. Cell Biol. 18, 1379–1387 (1998). Helped to define the molecular and functional relationships between the regulatory and catalytic subunits of PI3K.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Asano, T. et al. p110β is up-regulated during differentiation of 3T3-L1 cells and contributes to the highly insulin-responsive glucose transport activity. J. Biol. Chem. 275, 17671–17676 (2000).

    Article  CAS  PubMed  Google Scholar 

  57. Tanti, J. F., Gremeaux, T., Van Obberghen, E. & Le Marchand-Brustel, Y. Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem. J. 304, 17–21 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Tanti, J. F., Gremeaux, T., van Obberghen, E. & Le Marchand-Brustel, Y. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J. Biol. Chem. 269, 6051–6057 (1994).

    Article  CAS  PubMed  Google Scholar 

  59. Antonetti, D. A., Algenstaedt, P. & Kahn, C. R. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol. Cell Biol. 16, 2195–2203 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Ueki, K. et al. Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase. Proc. Natl Acad. Sci. USA 99, 419–424 (2002).

    Article  CAS  PubMed  Google Scholar 

  61. Terauchi, Y. et al. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 α subunit of phosphoinositide 3-kinase. Nature Genet. 21, 230–235 (1999). The first description of the paradoxical negative regulation of insulin signalling by the regulatory subunit p85α.

    Article  CAS  PubMed  Google Scholar 

  62. Chen, D. et al. p50α/p55α phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity. Mol. Cell Biol. 24, 320–329 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Fruman, D. A. et al. Hypoglycaemia, liver necrosis and perinatal death in mice lacking all isoforms of phosphoinositide 3-kinase p85 α. Nature Genet. 26, 379–382 (2000).

    Article  CAS  PubMed  Google Scholar 

  64. Mauvais-Jarvis, F. et al. Reduced expression of the murine p85α subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J. Clin. Invest. 109, 141–149 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Barbour, L. A. et al. Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle. Endocrinology 145, 1144–1150 (2004). Shows that the physiologic upregulation of p85α in vivo induces insulin resistance.

    Article  CAS  PubMed  Google Scholar 

  66. Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J. & Olefsky, J. M. Increased p85/55/50 expression and decreased phosphatidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 54, 2351–2359 (2005).

    Article  CAS  PubMed  Google Scholar 

  67. Ueki, K., Algenstaedt, P., Mauvais-Jarvis, F. & Kahn, C. R. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85α regulatory subunit. Mol. Cell Biol. 20, 8035–8046 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Luo, J., Field, S. J., Lee, J. Y., Engelman, J. A. & Cantley, L. C. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J. Cell Biol. 170, 455–464 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Ueki, K. et al. Positive and negative roles of p85 α and p85 β regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J. Biol. Chem. 278, 48453–48466 (2003). The first published connection between the p85α regulatory subunit and JNK activation.

    Article  CAS  PubMed  Google Scholar 

  70. Carpenter, C. L. & Cantley, L. C. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8, 153–158 (1996).

    Article  CAS  PubMed  Google Scholar 

  71. Fang, D. & Liu, Y. C. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nature Immunol. 2, 870–875 (2001).

    Article  CAS  Google Scholar 

  72. Zheng, Y., Bagrodia, S. & Cerione, R. A. Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85. J. Biol. Chem. 269, 18727–18730 (1994).

    Article  CAS  PubMed  Google Scholar 

  73. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M. & Hemmings, B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785–789 (1995).

    Article  CAS  PubMed  Google Scholar 

  74. Frame, S. & Cohen, P. GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359, 1–16 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Sano, H. et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 278, 14599–14602 (2003).

    Article  CAS  PubMed  Google Scholar 

  76. Harris, T. E. & Lawrence, J. C. Jr. TOR signaling. Sci. STKE 2003, RE15 (2003).

    Article  PubMed  Google Scholar 

  77. Tran, H., Brunet, A., Griffith, E. C. & Greenberg, M. E. The many forks in FOXO's road. Sci. STKE 2003, RE5 (2003).

    Article  PubMed  Google Scholar 

  78. Puigserver, P. et al. Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction. Nature 423, 550–555 (2003).

    Article  CAS  PubMed  Google Scholar 

  79. Nakae, J. et al. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 4, 119–129 (2003).

    Article  CAS  PubMed  Google Scholar 

  80. Wolfrum, C., Asilmaz, E., Luca, E., Friedman, J. M. & Stoffel, M. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432, 1027–1032 (2004).

    Article  CAS  PubMed  Google Scholar 

  81. Brazil, D. P., Yang, Z. Z. & Hemmings, B. A. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29, 233–242 (2004).

    Article  CAS  PubMed  Google Scholar 

  82. Gao, T., Furnari, F. & Newton, A. C. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell 18, 13–24 (2005).

    Article  CAS  PubMed  Google Scholar 

  83. Du, K., Herzig, S., Kulkarni, R. N. & Montminy, M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300, 1574–1577 (2003).

    Article  CAS  PubMed  Google Scholar 

  84. Koo, S. H. et al. PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3. Nature Med. 10, 530–534 (2004).

    Article  CAS  PubMed  Google Scholar 

  85. Chen, W. S. et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203–2208 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F. & Birnbaum, M. J. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276, 38349–38352 (2001).

    Article  CAS  PubMed  Google Scholar 

  87. Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292, 1728–1731 (2001).

    Article  CAS  PubMed  Google Scholar 

  88. George, S. et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304, 1325–1328 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Tschopp, O. et al. Essential role of protein kinase B γ (PKB γ/Akt3) in postnatal brain development but not in glucose homeostasis. Development 132, 2943–2954 (2005).

    Article  CAS  PubMed  Google Scholar 

  90. Chan, T. O., Rittenhouse, S. E. & Tsichlis, P. N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68, 965–1014 (1999).

    Article  CAS  PubMed  Google Scholar 

  91. Bae, S. S., Cho, H., Mu, J. & Birnbaum, M. J. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J. Biol. Chem. 278, 49530–49536 (2003).

    Article  CAS  PubMed  Google Scholar 

  92. Jiang, Z. Y. et al. Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc. Natl Acad. Sci. USA 100, 7569–7574 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. Calera, M. R. et al. Insulin increases the association of Akt-2 with Glut4-containing vesicles. J. Biol. Chem. 273, 7201–7204 (1998).

    Article  CAS  PubMed  Google Scholar 

  94. Yamada, E. et al. Akt2 phosphorylates Synip to regulate docking and fusion of GLUT4-containing vesicles. J. Cell Biol. 168, 921–928 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Masure, S. et al. Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. Eur. J. Biochem. 265, 353–360 (1999).

    Article  CAS  PubMed  Google Scholar 

  96. Standaert, M. L., Bandyopadhyay, G., Kanoh, Y., Sajan, M. P. & Farese, R. V. Insulin and PIP3 activate PKC-ζ by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites. Biochemistry 40, 249–255 (2001).

    Article  CAS  PubMed  Google Scholar 

  97. Farese, R. V. Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am. J. Physiol. Endocrinol. Metab. 283, E1–E11 (2002).

    Article  CAS  PubMed  Google Scholar 

  98. Farese, R. V., Sajan, M. P. & Standaert, M. L. Atypical protein kinase C in insulin action and insulin resistance. Biochem. Soc. Trans. 33, 350–353 (2005).

    Article  CAS  PubMed  Google Scholar 

  99. Pouyssegur, J., Volmat, V. & Lenormand, P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem. Pharmacol. 64, 755–763 (2002).

    Article  CAS  PubMed  Google Scholar 

  100. Pages, G. et al. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science 286, 1374–1377 (1999).

    Article  CAS  PubMed  Google Scholar 

  101. Bost, F. et al. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54, 402–411 (2005).

    Article  CAS  PubMed  Google Scholar 

  102. Hancock, J. F. & Parton, R. G. Ras plasma membrane signalling platforms. Biochem. J. 389, 1–11 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Rodriguez-Viciana, P. et al. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527–532 (1994).

    Article  CAS  PubMed  Google Scholar 

  104. Wellbrock, C., Karasarides, M. & Marais, R. The RAF proteins take centre stage. Nature Rev. Mol. Cell Biol. 5, 875–885 (2004).

    Article  CAS  Google Scholar 

  105. Matos, P. et al. Small GTPase Rac1: structure, localization, and expression of the human gene. Biochem. Biophys. Res. Commun. 277, 741–751 (2000).

    Article  CAS  PubMed  Google Scholar 

  106. Marks, P. W. & Kwiatkowski, D. J. Genomic organization and chromosomal location of murine Cdc42. Genomics 38, 13–18 (1996).

    Article  CAS  PubMed  Google Scholar 

  107. Marcusohn, J., Isakoff, S. J., Rose, E., Symons, M. & Skolnik, E. Y. The GTP-binding protein Rac does not couple PI 3-kinase to insulin-stimulated glucose transport in adipocytes. Curr. Biol. 5, 1296–1302 (1995).

    Article  CAS  PubMed  Google Scholar 

  108. Usui, I., Imamura, T., Huang, J., Satoh, H. & Olefsky, J. M. Cdc42 is a Rho GTPase family member that can mediate insulin signaling to glucose transport in 3T3-L1 adipocytes. J. Biol. Chem. 278, 13765–13774 (2003).

    Article  CAS  PubMed  Google Scholar 

  109. Ip, Y. T. & Davis, R. J. Signal transduction by the c-Jun N-terminal kinase (JNK) — from inflammation to development. Curr. Opin. Cell Biol. 10, 205–219 (1998).

    Article  CAS  PubMed  Google Scholar 

  110. Zarubin, T. & Han, J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15, 11–18 (2005).

    Article  CAS  PubMed  Google Scholar 

  111. Furtado, L. M., Somwar, R., Sweeney, G., Niu, W. & Klip, A. Activation of the glucose transporter GLUT4 by insulin. Biochem. Cell Biol. 80, 569–578 (2002).

    Article  CAS  PubMed  Google Scholar 

  112. Carlson, C. J., Koterski, S., Sciotti, R. J., Poccard, G. B. & Rondinone, C. M. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 52, 634–641 (2003).

    Article  CAS  PubMed  Google Scholar 

  113. Chiang, S. H. et al. TCGAP, a multidomain Rho GTPase-activating protein involved in insulin-stimulated glucose transport. EMBO J. 22, 2679–2691 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Thien, C. B. & Langdon, W. Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nature Rev. Mol. Cell Biol. 2, 294–307 (2001).

    Article  CAS  Google Scholar 

  115. Molero, J. C. et al. c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. J. Clin. Invest. 114, 1326–1333 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Zhou, Q. L. et al. Analysis of insulin signalling by RNAi-based gene silencing. Biochem. Soc. Trans. 32, 817–821 (2004).

    Article  CAS  PubMed  Google Scholar 

  117. Stegmeier, F., Hu, G., Rickles, R. J., Hannon, G. J. & Elledge, S. J. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc. Natl Acad. Sci. USA 102, 13212–13217 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Shinagawa, T. & Ishii, S. Generation of Ski-knockdown mice by expressing a long double-strand RNA from an RNA polymerase II promoter. Genes Dev. 17, 1340–1345 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Ding, S. et al. Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 122, 473–483 (2005).

    Article  CAS  PubMed  Google Scholar 

  120. Becker, A. B. & Roth, R. A. Insulin receptor structure and function in normal and pathological conditions. Annu. Rev. Med. 41, 99–115 (1990).

    Article  CAS  PubMed  Google Scholar 

  121. Goren, H. J., White, M. F. & Kahn, C. R. Separate domains of the insulin receptor contain sites of autophosphorylation and tyrosine kinase activity. Biochemistry 26, 2374–2382 (1987).

    Article  CAS  PubMed  Google Scholar 

  122. Sesti, G. et al. Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein. Acta Diabetol. 31, 59–65 (1994).

    Article  CAS  PubMed  Google Scholar 

  123. Yamaguchi, Y. et al. Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Endocrinology 129, 2058–2066 (1991).

    Article  CAS  PubMed  Google Scholar 

  124. Leibiger, B. et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic β cells. Mol. Cell 7, 559–570 (2001).

    Article  CAS  PubMed  Google Scholar 

  125. Bhalla, U. S. & Iyengar, R. Emergent properties of networks of biological signaling pathways. Science 283, 381–387 (1999).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by National Institutes of Health grants, and a Joslin Diabetes and Endocrinology Research Center grant (to C.R.K.). C.M.T. acknowledges support from the American Diabetes Association Medical Scholars Award and the Medical Scientist Training Program (Harvard Medical School). B.E. was supported by a National Institutes of Health grant. We apologize to the authors whose work could not be cited in this review due to space limitations, but appreciate all of the many contributions to the large body of literature we have tried to summarize here.

Author information

Author notes

  1. Cullen M. Taniguchi, Brice Emanuelli and C. Ronald Kahn: These authors contributed equally to this work.

Authors and Affiliations

  1. Joslin Diabetes Center, One Joslin Place, Boston, 02215, Massachusetts, USA

    Cullen M. Taniguchi, Brice Emanuelli & C. Ronald Kahn

Authors
  1. Cullen M. Taniguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brice Emanuelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Ronald Kahn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Ronald Kahn.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

FURTHER INFORMATION

C. Ronald Kahn's homepage

Glossary

Critical node

A point in a signalling network that is essential for the biological function of a ligand–receptor interaction, but also allows divergence of the signal to facilitate crosstalk between systems and/or to fine-tune the response to stimuli.

Insulin receptor substrate protein

(IRS protein). A large protein scaffold that serves as a docking platform for other signalling proteins that contain Src-homology-2 domains. The IRS proteins are required for a complete insulin signal.

Receptor tyrosine kinase

(RTK). A cell-surface receptor with an intracellular tyrosine kinase domain. The ligand-mediated activation of an RTK results in the activation of the intracellular kinase domain.

Insulin resistance

Insulin resistance is a condition in which normal concentrations of insulin produce a subnormal biological response. It is common in many physiological and pathological states, including obesity, type-2 diabetes, metabolic syndrome, polycystic ovarian disease, pregnancy and puberty.

Pleckstrin-homology domain

(PH domain). A protein domain of ∼100 amino acids with homology to pleckstrin that mediates the binding to membrane phospholipids, such as PIP3.

Phosphotyrosine-binding domain

(PTB domain). A domain that mediates the binding to specific phosphotyrosine residues. The affinity of a PTB domain for a phosphotyrosine depends on the residues that surround the phosphotyrosine. For instance, the PTB domain of the IRS proteins binds to an NPXpY motif.

Src-homology-2 domain

(SH2 domain). A domain of ∼100 amino acids that binds to phosphotyrosine residues in proteins. Every protein's SH2 domain might have a slightly different phosphotyrosine-binding motif.

Transphosphorylation

The transfer of a phosphate by a protein kinase to a residue within the same kinase molecule, or to a different kinase molecule of the same kind.

Phosphotyrosine motif

A phosphorylated tyrosine residue that is flanked by a few different amino-acid residues. Different phosphotyrosine-binding proteins have varying affinities for different phosphotyrosine motifs, which explains, in part, the specificity of phosphotyrosine-binding proteins.

AGC kinases

A large family of serine/threonine kinases that includes members as diverse as the cAMP-dependent protein kinases, and protein kinase C. The members of this AGC subgroup include AKT/PKB, serum/glucocorticoid kinases and the atypical PKCs.

Src-homology-3 domain

(SH3 domain). A protein sequence of ∼50 amino acids that facilitates the binding to proline-rich regions of proteins. Binding of an SH3 domain to a proline-rich region can occur in an intramolecular or intermolecular fashion.

Breakpoint-cluster region homology domain

A ∼150-residue region of p85a with homology to the breakpoint-cluster region gene and homology to Rho-GTPase activating proteins, which decrease the activity of small GTPases. Despite this homology, the breakpoint-cluster region homology domain has not been demonstrated to have GTPase activity.

Diacylglycerol

(DAG). DAG is a lipid second messenger that is produced by the cleavage of PIP2 by phospholipase C. DAG is involved in the activation of conventional and novel protein kinase Cs (PKCs).

GLUT4 translocation

Relocalization and fusion of an intracellular vesicle that contains the glucose transporter GLUT4 to the plasma membrane. It allows the uptake of extracellular glucose that is stimulated by insulin in muscle and adipose tissues.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taniguchi, C., Emanuelli, B. & Kahn, C. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7, 85–96 (2006). https://doi.org/10.1038/nrm1837

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrm1837

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing